Effect of intraventricular injections of dihydro-beta-erythroidine (DH βE) on spatial memory in the rat

Brain Research

Volumn 714, Issue 1-2, 1996, Pages 185-191

  Curzon, Peter ^a   Brioni, Jörge D ^a   Decker, Michael W ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Dihydro beta erythroidine; Morris water maze; Nicotinic antagonist; Radial arm maze; Rat; Spatial memory

Indexed keywords

DIHYDRO BETA ERYTHROIDINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; MAZE TEST; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

ANIMALS; DIHYDRO-BETA-ERYTHROIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; MALE; MAZE LEARNING; MEMORY; RATS;

EID: 0029923722     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01536-1     Document Type: Article

References (38)

1. Acri, J.B., Nicotine modulates effects of stress on acoustic startle reflexes in rats: dependence on dose, stressor and initial reactivity. Psychopharmacology, 116 (1994) 255-265.
2. Acri, J.B., Grunberg, N.E. and Morse, D.E., Effects of nicotine on the acoustic startle reflex amplitude in rats, Psychopharmacology, 10 (1991) 244-28.
3. Acri, J.B., Morse D.E., Popke, E.J. and Grunberg, N.E., Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats, Psychopharmacology, 114 (1994) 369-374.
4. 3H]Mecamylamine binding to rat brain membranes, Biochem. Pharmacol., 40 (1990) 2105-2110.
5. 3 receptor antagonist, on cognition in rodents and primates, Pharmacol. Biochem. Behav., 35 (1989) 955-962.
6. Brucato, F.H., Levin, E.D., Rose, J.E. and Swartzwelder, H.S., Intracerebroventricular nicotine and mecamylamine alter radial-arm maze performance in rats, Drug Dev. Res., 31 (1994) 18-23.
7. Clarke, P.B.S., The fall and rise of neuronal α-bungarotoxin binding proteins. Trends Pharmacol. Sci., 13 (1992) 407-413.
8. Clarke, P.B.S. and Fibiger, H.C., Reinforced alternation performance is impaired by muscarinic but not by nicotinic receptor blockade in rats, Behav. Brain Res., 36 (1990) 203-207.
9. Clarke, P.B.S. and Kumar, R., Characterization of the locomotor stimulant action of nicotine in tolerant rats, Br. J. Pharmacol., 80 (1983) 587-594.
10. Clarke, P.B.S. and Kumar, R., The effects of nicotine on locomotor activity in non-tolerant and tolerant rats, Br. J. Pharmacol., 78 (1983) 329-337.
11. Corrigall, W.A. and Coen, K.M., Selective dopamine antagonists reduce nicotine self-administration, Psychopharmacology, 104 (1991) 171-176.
12. Corrigall, W.A., Coen, K.M. and Adamson, K.L., Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area, Brain Res., 653 (1994) 278-284.
13. Cozzolino, R., Guaraldi, D., Giuliana, A., Ghirardi, O., Ramacci, M.T. and Angelucci, L., Effect of concomitant nicotinic and muscarinic blockade on spatial memory disturbance in rats are purely additive: Evidence from the Morris water task, Physiol. Behav., 56 (1994) 111-114.
14. Curzon, P., Brioni, J.D. and Decker, M.W., Behavioral effects of nicotinic cholinergic receptor (nAChR) blockade with dihydro-β-erythroidine (DH β E) and methllycoconatine (MLA), Neurosci. Abstr., 20 (1994) 150.
15. Curzon, P., Kim, D.J.B. and Decker, M.W., Effect of nicotine, lobeline and mecamylamine on sensory gating in the rat, Pharmacol. Biochem. Behav., 49 (1994) 877-882.
16. Decker, M.W., Anderson, D.J., Brioni, J.D., Donnelly-Roberts, D.L., Kang, C.H., O'Neill, A.B., Piattoni-Kaplan, M., Swanson, S. and Sullivan, J.P., Erysodine, a competitive antagonist at neuronal nicotinic acetycholine receptors, Eur. J. Pharmacol, 280 (1995) 79-89.
17. Decker, M.W., Brioni, J.D., Bannon, A.W. and Arneric, S.P., Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implicationd for CNS therapeutics, Life Sci., 56 (1994) 554-570.
18. Decker, M.W. and Majchrzak, M.J., Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats. Psychopharmacology, 107 (1992) 530-53.
19. Decker, M.W. and Majchrzak, M.J., Effects of central nicotinic cholinergic receptor blockade produced by chlorisondamine on learning and memory performance in rats, Behav. Neural Biol., 60 (1993) 163-171.
20. Eagan, T.M. and North, R.A., Actions of acetylcholine and nicotine on rat locus coeruleus neurons in vitro. Neuroscience, 19 (1986) 565-571.
21. El-Bizri, H. and Clarke, P.B.S., Blockade of nicotinic-receptor mediated release of dopamine from striatal synaptosomes by clorisondamine and other nicotinic antagonists administered in vitro, Br. J. Pharmacol., 111 (1994) 406-413.
22. Elselé, J.L., Bertrand, S., Galzi, J.L., Devillers-Thiery, A., Changeux, J.P. and Bertrand, D., Chimeaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities, Nature, 366 (1993) 479-483.
23. Flores, C.M., Rogers, S.W., Pabreza, L.A., Wolfe, B.B. and Kellar, K.J., A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment, Mol. Pharmacol., 41 (1991) 31-37.
24. Games, P.A. and Howell, J.F., Pairwise multiple comparison procedures with unequal N's and/or variances, J. Educ. Stat., 1 (1976) 113-125.
25. 3H]dopamine release from synaptosomes prepared from mouse striatum., J. Neurochem., 59 (1992) 848-856.
26. Granon, S., Poucet, B., Thinus-Blanc, C., Changeux, J.P. and Vidai, C., Nicotinic and muscarinic receptors in the rat prefrontal cortex: Differential roles of working memory, response selection and effortful processing, Psychopharmacology, 119 (1995) 139-144.
27. Keselman, H.J. and Rogan, J.C., A comparison of the modified-Tukey and Scheffe methods of multiple comparisons for pairwise contrasts, J. Am. Stat. Assoc., 73 (1978) 47-52.
28. Levin, E.D., Briggs, S.J., Christopher, N.C. and Rose, J.E., Persistence of chronic nicotine-induced cognitive facilitation., Behav. Neural Biol., 58 (1992) 152-158.
29. Levin, E.D., Christopher, N.C., Briggs, S.J. and Rose, J.E., Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Cog. Brain Res., 1 (1993) 137-143.
30. Levin, E.D. and Rose, J.E., Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze, Brain Res. Bull., 27 (1991) 125-128.
31. Luetje, C.W. and Patrick, J.W., Members of the neuronal nicotinic acetylcholine receptor family display distinct pharmacological and toxicological properties, Neurosci. Abstr., 15 (1989) 677.
32. Luetje, C.W., Wada, K., Rogers, S., Abramson, S.N., Tsuji, K., Heinemann, S. and Patrick, J., Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations, J. Neurochem., 55 (1990) 632-640.
33. Morris, R.G.M., Anderson, E., Lynch, G.S. and Baudry, M., Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5, Nature, 319 (1986) 774-776.
34. Overton, D.A., State-dependent learning produced by depressant and atropine-like drugs, Psychopharmacology, 10 (1966) 6-31.
35. 3H]Cytisine binding to nicotinic cholinergic receptors in brain, Mol. Pharmacol., 39 (1990) 9-12.
36. Parada-Turska, J. and Turski, W.A., Excitatory amino acid antagonists and memory: Effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks, Neuropharmacology, 29 (1990) 1111-1116.
37. Wada, E., Wada, K., Boulter, J., Deneris, E., Heinemann, S., Patrick, J. and Swanson, L.W., Distribution of alpha3, alpha4 and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat., J. Comp. Neurol., 284 (1989) 314-335.
38. Williams, M. and Robinson, J.L., Binding of the nicotine cholinergic antagonist, dihydro-β-erythroidine, to rat brain tissue, J. Neurosci., 4 (1984) 2906-2911.